Glyceryl Trinitrate
Also known as nitroglycerin.
Trade name
DBL Glyceryl Trinitrate, Glyceryl Trinitrate Wockhardt
Presentation and preparation
DBL Glyceryl Trinitrate: 5 mg/mL (volume: 10 mL)
Glyceryl Trinitrate Wockhardt: 1 mg/mL (volume: 50 mL)
IV administration
Dilute to 400 microgram/mL or weaker and give as a continuous infusion.
Maximum concentration if necessary: 1 mg/mL via a central line only.
Non-PVC bags and giving sets should be used.
Many in-line filters adsorb glyceryl trinitrate and should be avoided.
Other routes of administration
IM: Not recommended.
SC: Not recommended.
Compatible IV fluids
Glucose 5%
Sodium chloride 0.9%
Glyceryl Trinitrate 400 microgram/mL or weaker only:
Glucose 5% and sodium chloride 0.9%
Glucose 5% and sodium chloride 0.45%
DBL Glyceryl trinitrate 400 microgram/mL or weaker only:
Hartmann’s
Caution: Y-site medicine and fluid administration may inadvertently change the infusion rate of glyceryl trinitrate.
DBL Glyceryl Trinitrate Y-site only and glyceryl trinitrate 600 microgram/mL or weaker only:
Plasma-Lyte 148
DBL Glyceryl Trinitrate Y-site only:
Potassium chloride 20 mmol/L
Additional information
Use only when facilities for cardiac monitoring and cardio-respiratory resuscitation exist.
Tolerance may develop within 24 – 48 hours of continuous use; a daily nitrate-free interval may be required.
Taper the infusion slowly when discontinuing prolonged treatment; abrupt discontinuation may cause a withdrawal reaction.
Use with caution in neonates; contains propylene glycol, which can cause CNS depression, hyperosmolality, metabolic acidosis and renal impairment.
DBL glyceryl trinitrate contains alcohol: Alcohol intoxication has occurred using high dose intravenous infusions.
Protect from light during storage.